| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/26/2002 | US20020137023 Methods and compositions for targeting compounds to muscle |
| 09/26/2002 | US20020137020 Spliced gene of KSHV / HHV8, its promoter and monoclonal antibodies specific for LANA2 |
| 09/26/2002 | US20020136978 Transfer of arrayed chemical compositions |
| 09/26/2002 | US20020136769 Nanogel networks including polyion polymer fragments and biological agent compositions thereof |
| 09/26/2002 | US20020136726 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 09/26/2002 | US20020136710 Methods and formulations for mediating adeno-associated virus (AAV) attachment and infection and methods for purifying AAV |
| 09/26/2002 | US20020136709 Producing human pluripotent stem cells from human adult somatic cells by treating adult somatic cells with agent that promotes cellular reprogramming |
| 09/26/2002 | US20020136708 System for production of helper dependent adenovirus vectors based on use of endonucleases |
| 09/26/2002 | US20020136707 Human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof |
| 09/26/2002 | US20020136704 Method for determining susceptibility of thymus in patient to activation through disruption of sex steroid signaling to thymus |
| 09/26/2002 | US20020135085 Production scale method of forming microparticles |
| 09/26/2002 | CA2441902A1 Chimpanzee erythropoietin (chepo) - immunoadhesins |
| 09/26/2002 | CA2441815A1 Method and composition for treatment of skeletal dysplasias |
| 09/26/2002 | CA2441510A1 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 09/26/2002 | CA2441388A1 Modified insulin with reduced immunogenicity |
| 09/26/2002 | CA2441291A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 09/26/2002 | CA2441086A1 Identification of gene expression alterations underlying the aging process in mammals |
| 09/26/2002 | CA2440844A1 Two-phase processing of thermosensitive polymers for use as biomaterials |
| 09/26/2002 | CA2439916A1 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/26/2002 | CA2439757A1 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells |
| 09/26/2002 | CA2439532A1 Methods and reagents for regulating apoptosis |
| 09/26/2002 | CA2439315A1 Compositions useful in gene therapy |
| 09/25/2002 | EP1243655A1 Modified HPV E6 and E7 genes and proteins useful for vaccination |
| 09/25/2002 | EP1242617A2 Method of classifying a thyroid carcinoma using differential gene expression |
| 09/25/2002 | EP1242611A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 09/25/2002 | EP1242609A2 Novel colloid synthetic vectors for gene therapy |
| 09/25/2002 | EP1242608A2 Method of achieving persistent transgene expression |
| 09/25/2002 | EP1242592A2 A molecular switch for regulating mammalian gene expression |
| 09/25/2002 | EP1242590A2 Human lyases and associated proteins |
| 09/25/2002 | EP1242587A1 A NOVEL ISOFORM OF HUMAN cAMP-DEPENDENT PROTEIN KINASE, C ALPHA-s, LOCALIZES TO SPERM MIDPIECE AND THE USE THEREOF |
| 09/25/2002 | EP1242585A1 IDENTIFICATION OF NOVEL SPLICE VARIANTS OF THE HUMAN CATALYTIC SUBUNIT C BETA OF cAMP-DEPENDENT PROTEIN KINASE AND THE USE THEREOF |
| 09/25/2002 | EP1242456A2 Scfv antibodies against disease associated molecules |
| 09/25/2002 | EP1242449A1 Modified adenovirus fibre and uses |
| 09/25/2002 | EP1242124A1 Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 pol |
| 09/25/2002 | EP1242112A1 Particulate drug-containing products and method of manufacture |
| 09/25/2002 | EP1242111A1 An animal model for studying hormone signalling and method of modulating the signalling |
| 09/25/2002 | EP1242106A1 Carbon dioxide enhancement of inhalation therapy |
| 09/25/2002 | EP1242050A2 Survivin promotion of angiogenesis |
| 09/25/2002 | EP1241935A2 Methods for producing transgenic animals |
| 09/25/2002 | EP1175432A4 Processes for the synthesis of oligomers using phosphoramidite compositions |
| 09/25/2002 | EP1159000B1 Preparation for the treatment of pigmentation disorders |
| 09/25/2002 | EP1146897B1 Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair |
| 09/25/2002 | EP0981549B1 Use of an inhibitor substance for the improvement of neuronal regeneration |
| 09/25/2002 | EP0980263B1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy |
| 09/25/2002 | EP0918540B1 Intradermal bovine polynucleotide vaccine |
| 09/25/2002 | EP0845981B1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
| 09/25/2002 | EP0804591B1 Serum paraoxonase |
| 09/25/2002 | CN1371390A Human G-protein coupled receptor |
| 09/25/2002 | CN1371389A 疫苗 Vaccine |
| 09/25/2002 | CN1371378A 28-epirapalogs |
| 09/25/2002 | CN1371366A Benzamide formulation with histone deacetylase inhibitor activity |
| 09/25/2002 | CN1371289A Gene therapy using TGF-beta |
| 09/24/2002 | US6455689 Antisense-oligonucleotides for transforming growth factor-β (TGF-β) |
| 09/24/2002 | US6455686 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 09/24/2002 | US6455683 Nucleotidesequences coding protein for use in the prevetion and treatment of infectious, inflammatory and allergic diseases |
| 09/24/2002 | US6455674 Polypeptide for use in the diagnosis and treatment of tissue oxygenation defects |
| 09/24/2002 | US6455536 Treatment of dyskinesia |
| 09/24/2002 | US6455497 Methods and materials for treating inflammatory diseases |
| 09/24/2002 | US6455314 Recombinant fiber protein having a trimerization domain and which interacts with adenoviral penton base; for gene transfer methods |
| 09/24/2002 | US6455305 Nucleotide sequence of gene involved in cancer; anticarcinogenic agents |
| 09/24/2002 | US6455290 Tankyrase homolog protein (THP), nucleic acids, and methods related to the same |
| 09/24/2002 | US6455278 Nucleic acid which encodes protein of defined amino acid sequence involved in pain perception; analgesics |
| 09/24/2002 | US6455253 Methods and compositions for polypeptide engineering |
| 09/24/2002 | US6455044 5c8 antigen |
| 09/24/2002 | US6455040 Sometimes referred to as ?tnfr-5? or ?tr5,? and now referred to hereinafter as ?trail receptor without intracellular domain? or ?trid.? |
| 09/20/2002 | CA2342376A1 A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 09/19/2002 | WO2002072853A1 Avidin-pseudotyped viral vectors and their use |
| 09/19/2002 | WO2002072852A2 Leporipox-based vector vaccines |
| 09/19/2002 | WO2002072826A2 Neurotrophic factors |
| 09/19/2002 | WO2002072822A2 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 09/19/2002 | WO2002072798A1 Fas ligand-expressing hematopoietic cells for transplantation |
| 09/19/2002 | WO2002072796A2 Continuous, normal human t-lymphocyte cell lines comprising a recombinant immune receptor with defined antigen specificity |
| 09/19/2002 | WO2002072790A2 Tsg101-gag interaction and use thereof |
| 09/19/2002 | WO2002072787A2 Telomerase expression repressor proteins and methods of using the same |
| 09/19/2002 | WO2002072763A2 Nucleic acids, proteins, and antibodies |
| 09/19/2002 | WO2002072754A2 Mva expressing modified hiv envelope, gag, and pol genes |
| 09/19/2002 | WO2002072753A2 Thymidylate synthase peptides that bind to thymidylate synthase messenger rna |
| 09/19/2002 | WO2002072632A2 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
| 09/19/2002 | WO2002072616A2 Transfection complexes |
| 09/19/2002 | WO2002072596A1 Steap-related protein |
| 09/19/2002 | WO2002072152A1 Gene carriers with the use of polysaccharide and process for producing the same |
| 09/19/2002 | WO2002072140A2 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro |
| 09/19/2002 | WO2002072130A1 Method of preventing adhesions by apoptosis of adhesion peritoneal cells |
| 09/19/2002 | WO2002072127A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 09/19/2002 | WO2002072079A2 Modulators of the ank-pyrophosphate channel for use in osteoporosis therapy |
| 09/19/2002 | WO2002072028A2 Compositions and methods for modifying the content of polyunsaturated fatty acids in mammalian cells |
| 09/19/2002 | WO2002072027A2 Oncolytic rna replicons |
| 09/19/2002 | WO2002072019A2 Interferon-beta polynucleotide therapy for autoimmune and inflammatory diseases |
| 09/19/2002 | WO2002072013A2 Method of treating malignancies through induction of blood immune responses |
| 09/19/2002 | WO2002071843A1 Recombinant adeno-assocaited virus-mediated gene transfer via retroductal infusion of virions |
| 09/19/2002 | WO2002055663A3 Srebp pathway modulation through targeting hisrs |
| 09/19/2002 | WO2002033119A9 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 09/19/2002 | WO2002033079A3 Human g-protein coupled receptor and uses thereof |
| 09/19/2002 | WO2002026765A3 Haplotypes of the muc1 gene |
| 09/19/2002 | WO2002022871A3 Polymorphic bone morphogenetic protein 2 |
| 09/19/2002 | WO2002022825A9 The c. albicans tec1 gene (catec1) and the coded tec1p protein |
| 09/19/2002 | WO2002022631A3 Regulation of human pyroglutamyl peptidase-like enzyme |
| 09/19/2002 | WO2002017949A9 Novel functions for dp214 |
| 09/19/2002 | WO2002010379A3 Modified cea and uses thereof |
| 09/19/2002 | WO2002005792A9 Use of matrix metalloprotease inhibitors for the treatment of cancer |